Back

Non-linear association between the triglyceride-glucose index and all-cause and cardiovascular mortality in diabetes mellitus patients with hypertension: a retrospective cohort study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Interaction between hypertension and diabetes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yuanyuan Zhao

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

4 More presentations in this session

Presentation thumbnail
Rising mortality related to diabetes mellitus and hypertension: trends and disparities in the United States (1999-2023)
Doctor C. Ranasinghe (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Hypertension related vs diabetes related cardiovascular deaths which is the bigger killer? a USA mortality trend analysis using CDC WONDER
Doctor M. Khan (Newcastle-Upon-Tyne, GB)
Abstract Slides Video
Presentation thumbnail
Gender differences in hypertension vs. diabetes cardiovascular mortality A CDC WONDER study
Doctor P. Sajnani (Plymouth, GB)
Abstract Slides Video
Presentation thumbnail
Factors associated with poor blood pressure control in type 2 diabetic hypertensive patients
Professor A. Bachir-Cherif (Blida, DZ)
Abstract Slides Video

Access the full session

Session thumbnail
Interaction between hypertension and diabetes

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The triglyceride-glucose index is a predictor for cardiovascular events and all-cause mortality in young and middle-aged patients with metabolic syndrome
thumbnail
Congress Presentation
The associations of triglyceride glucose and its derived indexes with 10-year cardiovascular disease risk in a Chinese community-based population
thumbnail
Congress Presentation
Relationship between triglyceride-to-glucose index in addition to waist circumference as a marker of insulin resistance and mean arterial pressure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources